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Background: Association of vitamin D deficiency with coronary heart disease (CHD) has
been widely reported. Emerging data has shown high prevalence of vitamin D deficiency
among Indians. However, this association has not been studied in Indians.
Methods: A case-control study with 120 consecutive cases of first incident acute myocardial
infarction (MI) and 120 age and gender matched healthy controls was conducted at All
India Institute of Medical Sciences, New Delhi. The standard clinical and biochemical risk
factors for MI were assessed for both cases and controls. Serum 25 (OH) vitamin D assay
was performed from stored samples for cases and controls using radioimmunoassay.
Results: VitaminDdeficiency [25(OH)D< 30ng/ml]washighly prevalent in cases and controls
(98.3% and 95.8% respectively) with median levels lower in cases (6 ng/ml and 11.1 ng/ml
respectively; p < 0.001). The cases were more likely to have diabetes, hypertension and
consume tobacco and alcohol. They had higher waist hip ratio, total and LDL cholesterol.
Multivariate logistic regressionanalysis revealed severevitaminDdeficiency [25(OH)vitamin
D < 10 ng/ml] was associated with a risk of MI with an odds ratio of 4.5 (95% CI 2.2e9.2).
Conclusions: This study reveals high prevalence of vitamin D deficiency among cases of
acute MI and controls from India, with levels of 25 (OH)D being significantly lower among2; fax: þ91 11 26588663.
(A. Roy).
ociety of India. All rights reserved.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 2 7e3 228cases. Despite rampant hypovitaminosis, severe vitamin D deficiency was associated with
acute MI after adjusting for conventional risk factors. This association needs to be tested in
larger studies in different regions of the country.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Association of vitamin D deficiency with coronary heart dis-
ease (CHD) has been reported in a large number of studies and
reviews recently.1e8 There is also emerging body of evidence
linking vitamin D deficiency to early mortality,9,10 with
vitamin D being considered as one of the possible treatable
cardiovascular risk factors.8 Emerging data has shown high
prevalence of vitamin D deficiency among Indians despite the
availability of abundant sunshine in large parts of India. This
is true for both urban and rural populations and, in men and
women, with reported population of prevalence of 70e99%,
with severe deficiency (<10 ng/ml) being reported as 62% in
studies from Delhi.11e14 However, there is very little data on
the association of vitamin D with CHD in Indians. Thus, it
would be useful to study the association of this novel and
potentially reversible risk factor of CHD in our population
especially when CHD has gained epidemic proportions. We
analyzed serum 25 hydroxy [25(OH)] vitamin D levels in cases
of acute myocardial infarction (MI) and age matched controls
to study this association in Indians.2. Methods
The study was part of a case control study conducted at the
Department of Cardiology at All India Institute of Medical
Sciences (AIIMS), New Delhi between March 1999eJune 2001.
The study was approved by the Institute Ethics Committee at
AIIMS. Serum 25 hydroxy [25(OH)] vitamin D measurement
was performed on blood samples stored at the cardiac-
biochemistry laboratory at AIIMS at 70 C.
2.1. Study design
Consecutive consenting cases of first incident acute MI aged
25e75 years were recruited in the study. A questionnaire was
administered to assess the risk factors of MI and a fasting
blood sample was collected within 24 h of admission to the
hospital. Acute MI was diagnosed if the patient had charac-
teristic symptoms plus electrocardiogram changes indicative
of a new MI (new pathologic Q waves, at least 1 mm ST
elevation in any 2 or more contiguous limb leads or 2 mm ST
elevation in precordial leads or a new left bundle branch
block) with or without a elevated plasma level of creatine
kinase-MB isoform (CK-MB). Those with history of heart dis-
ease diagnosed more than 30 days prior to enrollment in the
study or with cardiogenic shock were excluded.
Controls werematched to cases by age (within 5 years) and
gender andwere individuals who had no previous diagnosis of
heart disease or history of exertional chest pain and normal
ECG. Controls were recruited from attendants or relatives ofnon cardiac patients from non cardiac wards or unrelated
attendants of cardiac patients or patients attending non-
cardiac outpatient clinics for disorders unrelated to known
or potential risk factors for MI. Cases and controls with preg-
nancy, known liver, thyroid or renal diseases or malignancy
were excluded. Additionally, for this study, controls were
selected if their blood has been collected within 30 days of
blood collected for their matched case.
Hypertension was defined as systolic pressure 140 mm
Hg and/or diastolic pressure 90 mm Hg or history of cur-
rent antihypertensive medication use. Fasting plasma
glucose 126 mg/dl or post-prandial plasma glucose
200 mg/dl or anti diabetic medication use was defined as
having diabetes mellitus (DM). Tobacco users were defined
as smoked/chewed tobacco users in the last six months and
having used it continuously for more than six months.
Alcohol users were defined as individuals having consumed
any form of alcohol in the last six months and who had
consumed it for at least six months continuously. Family
history of CHD was defined as history of CHD in first degree
relatives at an age less than 60 years. Any leisure time
physical activity was defined as non work related physical
activity at least once a week. Highest acquired educational
qualification was determined.
2.2. Sample size calculation
The sample size for this study was calculated for a two sided
significance of 0.05 and study power of 80%. Based on a control
exposure of 50% and an odds ratio of 2.1 (15,16) the calculated
sample size was 120 cases and 120 controls.
2.3. Biochemical analysis
Glucose was measured by glucose oxidase method using
commercially available kits (RANDOX, UK). Total Cholesterol
was measured from serum samples by CHOD-PAP enzymatic
method using commercially available kits (RANDOX, UK). HDL
Cholesterol was measured from serum samples by phospho-
tungistic precipitating method. Triglyceride was measured
from serum samples by enzymatic GPO-PAP method using
commercially available kit (RANDOX, UK). Serum 25 (OH) D
levels were analyzed from serum samples stored at 70 C
before analysis. 25 (OH) D was measured by chemilumines-
cent immunoassay method using commercially available kit
Liaison® 25OH Vitamin D TOTAL (DiaSorin, USA) on liaison
analyzer, USA.
2.4. Statistical analyses
Summary statistics of baseline participant characteristics
were calculated by case and control status. Case and control







Severe deficiency (<10 ng/ml) 95 (79.2%) 56 (46.7%) <0.001
Deficiency (10e<30 ng/ml) 23 (19.2%) 59 (49.2%)
Sufficient (30 ng/ml) 2 (1.7%) 5 (4.2%)
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continuous variables, and chi2 tests for categorical variables.
TheManneWhitneyU test was used for comparison of 25 (OH)
vitamin D levels across case and control groups. Categorical
variables are shown as counts and percentages and contin-
uous variables shown as means with standard deviation (SD)
or medians with inter-quartile range (SD). 25 (OH) vitamin D
status was determined as severe deficiency state when the
25(OH) vitamin D level was below 10 ng/ml.1 Multiple condi-
tional logistic regression was used to investigate the rela-
tionship between MI and severe vitamin D deficiency
controlling for other significant risk factors including age,
diabetes, hypertension, LDL cholesterol, tobacco use, central
obesity and education. Vitamin D status was taken as a binary
variable (severe deficiency Vs no severe deficiency). The ana-
lyses were repeated using vitamin D exposure as a continuous
variable after it was log transformed.3. Results
The baseline characteristics of the cases and controls were as
in Table 1. The cases more frequently had DM, hypertension,
and consumed tobacco and alcohol. They also had higher
mean waist hip ratio, total cholesterol and LDL cholesterol
levels. There was no difference in age, family history of CHD,
leisure physical activity, educational qualification, HDL
cholesterol and triglycerides between cases and controls. The
median 25(OH) vitaminD level was significantly lower in cases
as compared to controls (Table 1).
There was a significant difference in the distribution of






Age (Years) 51.9 ± 11.4 52.1 ± 11.0 0.8
Men (%) 88.3% 88.3% 1.0
Hypertension (%) 34.2% 12.5% <0.001
Diabetes (%) 40.0% 20.0% <0.001
Tobacco Use(%) 62.2% 47.1% 0.01







Waist Hip Ratio 0.96 ± 0.06 0.92 ± 0.07 <0.001
Total Cholesterol
(mean ± SD) (mg/dl)
194.1 ± 62.8 177.5 ± 39.1 0.01
HDL Cholesterol
(mean ± SD) (mg/dl)
39.1 ± 9.9 40.3 ± 10.4 0.3
LDL Cholesterol
(mean ± SD) (mg/dl)
123.7 ± 56.3 108.3 ± 38.5 0.01
Triglycerides
(mean ± SD) (mg/dl)








6.0 (3.9e9.0) 11.1 (6.5e18.3) <0.001and Fig. 1). There was a very high prevalence of vitamin D
deficiency in both cases and controls. The prevalence of se-
vere deficiency of vitamin D, defined as 25(OH) vitamin D less
than 10 ng/ml, was present in 79.2% of cases and 46.7% of
controls. Only 1.7% and 4.2% of cases and controls respectively
had sufficient vitamin D levels.
Using statistically significant and clinically relevant co-
variates it was observed that severe vitamin D deficiency
was associated with a risk of MI with an odds ratio of 4.5 (95%
CI 2.2e9.2) (Table 3). The association persisted when the
analysis was repeated using vitamin D exposure as a contin-
uous variable after it was log transformed.4. Discussion
This case control study of incident acute MI suggests that
deficiency of vitamin D, including severe deficiency, is highly
prevalent in Delhi, India (latitude 28.35). It revealed that
vitamin D level is even lower in cases as compared to controls.
Despite the rampant vitamin D deficiency, severe vitamin D
deficiency is associated with risk of acute MI even after
adjusting for the known risk factors of acute MI.
The high prevalence of vitamin D deficiency found in this
study is consistent with other studies from India. A rural
prevalence study in North Indians showed that though
vitamin D levels in rural subjects were significantly higher
than in urban Indians, the prevalence of vitamin D deficiency
[serum 25(OH) vitamin D < 20 ng/ml] in them was as high as
70%.11 Another study from Delhi, in healthy individuals above
50 years of age, revealed deficiency [serum 25(OH) vitamin
D < 20 ng/ml] in 91.2% including severe deficiency [serum
25(OH) vitamin D < 10 ng/ml] in 62% and vitamin D insuffi-
ciency [serum 25(OH) vitamin D levels 20e<30 ng/ml] in
additional 6.8% of the population.12 A study from Andhra
Pradesh similarly reported a very high prevalence of vitaminDFig 1 e Distribution of vitamin D levels among cases and
controls.
Table 3 e Association of vitamin D deficiency with acute






10 ng/dl 1 <0.001
<10 ng/dl 4.5 (2.2, 9.2)
Central Obesity (0.90 for men& 0.85 for women)
No 1 0.006
Yes 2.8 (1.3, 6.0)
Diabetes Mellitus
No 1 0.02
Yes 2.3 (1.1, 4.7)
Hypertension
No 1 0.07
Yes 2.1 (0.9, 4.7)
Tobacco use
No 1 0.06
Yes 1.9 (0.9, 3.8)
LDL Cholesterol
<130 1 0.7
130 1.1 (0.6, 2.3)
Alcohol use
No 1 0.12
Yes 1.7 (0.8, 3.4)
Education
Secondary and below 1 0.25
Above Secondary 1.5 (0.8, 2.9)
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was 88% and 94% in urban males and females respectively. In
rural areas the numbers were 84% and 99% in males and fe-
males respectively. The causes for high prevalence of Vitamin
D deficiency in Indians is attributed to dark-skin, lack of
adequate direct skin exposure to sunlight and lack of vitamin
D in predominant Indian diet.
The association of vitamin D with cardiovascular health
has been reported extensively recently. A large population
based study reported by Brøndum-Jacobsen et al, comparing
individuals with plasma 25(OH) vitamin D levels at the 1st to
4th percentile to individuals with levels at the 50th to 100th
percentile, revealed that the multivariable adjusted risk was
increased by 40% for ischemic heart disease, by 64% for
myocardial infarction, by 57% for early death and by 81% for
fatal ischemic heart disease/myocardial infarction in in-
dividuals with low vitamin D.10 In the meta-analyses of 18
studies in the same paper, the authors found that the risk of
ischemic heart disease and early death were increased by 39%
and 46% for lowest versus highest quartile of 25(OH) vitamin D
level. However, the cardiovascular benefits of vitamin D sup-
plementation are not proven and large-scale randomized tri-
als are ongoing like the VITAL study.
The only case control study from India on association of
vitamin D with CHD from Trivandrum in South Indians re-
ported an increased odds of ischemic heart disease among
patients with 25(OH) vitamin D levels >89 ng/ml compared to
those with lower levels (odds ratio 3.18, 95% CI 1.31e7.73).15
This study is unusual for the very high cut-off chosen to
assess effect of vitamin D on MI and also does not assess the
association of VitaminD deficiencywithMI.While the authors
of this study acknowledged that even strong and prolongedUVB light cannot be toxic, they suggested that the high intake
of foods rich in vitamin D could be deleterious. However other
case control studies have also shown association of low
vitaminDwithMI. In a nested case-control study of the Health
Professional Follow-Up Study (HPFS), men with vitamin D
deficiency (25(OH) vitamin D levels <15 ng/ml) were at
increased risk of MI (RR 2.09, 95% CI 1.24e3.54) compared to
men with 25(OH) vitamin D levels >30 ng/ml.16 A previous
case-control study in patients of acute MI performed in the
USA17 reported similar inverse association between 25(OH)
vitamin D levels and risk of acute MI. A more recent study
from Pakistan revealed that individuals with normal levels of
25(OH) vitaminD (>30 ng/ml) had lower risk ofMI as compared
to those with vitamin D deficiency even after adjusting for
known co-variates with an adjusted odds ratio of 0.82
(p < 0.01).18 Similarly a study by Syal et al from North India in
100 patients undergoing coronary angiography revealed more
severe coronary artery disease and greater endothelial
dysfunction among individuals with low vitamin D.19
Several mechanisms, direct and indirect, have been pro-
posed for the association of vitamin D with CHD.20 Vitamin D
could be related to CHD via blood pressure, glycemic control or
parathyroid hormone (PTH). An excess of PTH levels is known
to promote atherosclerosis,21 thus PTH excess associated with
vitamin D deficiency maybe one of the contributory factors to
CHD. Vitamin D deficiency is known to up-regulate Renin
Angiotensin Aldosterone System (RAAS) and lead to hyper-
trophy of smooth muscles and left ventricle, an adverse
marker of cardiovascular event.22,23 Additionally, the effects of
vitaminDdeficiency on type 2DMcould bemediatedby its role
on pancreatic b -cell function, insulin resistance, or inflam-
mation.24,25 Animal studies have revealed more direct role of
vitamin D on cardiomyocyte remodeling as well as on cardiac
relaxation and contractility.26,27 Vitamin D is also known to
down-regulate pro-inflammatory cytokines (e.g., TNF-a, IL-6)
and up-regulate anti-inflammatory cytokine (IL-10).20
Another interesting finding of this study is that alcohol use
was associated with increased risk of MI. This association cor-
roborates with the findings of the Indian arm of the INTER-
HEART study,28 a case control study of acute MI, and another
case control study of industrial population from India.29
This study has several strengths. The cases that were
recruited were incident thereby accounting for protopathic
bias (presence of preclinical disease prior to initiation into the
study which could result inmodification of risk factors) which
are very common in case control studies that evaluate chronic
diseases. The controls were recruited from same location and
in same season though the limitation of being hospital based
was present. Extensive phenotyping was carried out both in
cases and controls. However, there were several limitations of
the study including the case control study design with its
limitations. Information on physical activity was limited and
not detailed, with no data available on diet and skin
pigmentation. This is a small study and the exposure rate in
controls was higher than anticipated. Larger studies with
greater power from multiple centers and from different parts
of India are needed, but this is the best available data linking
Vitamin D to MI/CHD in Indians presently. Additionally there
is a poor representation of women in this study. The study is
observational and no causality of severe vitamin D deficiency
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 2 7e3 2 31can be proven. This is however the current status of all
vitamin D studies and unless the results of well designed and
adequately powered randomized control studies are not
published causality cannot be proven. The blood samples
analyzed are from stored archival samples. However, 25(OH)
vitamin D is a steroid and thus a stable molecule. Previous
studies have shown the stability of 25(OH) vitamin D in stored
samples over very long time periods up to 24 years.30
In conclusion, the study reveals a very high prevalence of
vitamin D deficiency among patients of acute MI and also
controls recruited in this study from Delhi, India, with levels
of serum 25 (OH) vitamin D being significantly lower among
cases. Despite the rampant hypovitaminosis, presence of se-
vere vitamin D deficiency was associated with risk of acute MI
even after adjusting for conventional risk factors. This asso-
ciation needs to be tested in larger cross-sectional and cohort
studies from India. Meanwhile, population awareness of high
deficiency of vitamin D must be created and its skeletal and
possible cardiovascular harm should be mitigated by
encouraging sun exposure and food fortification.5. Author contribution
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